Oncolys BioPharma, Inc. (4588)
Tokyo Stock Exchange · Health Technology
Not compliant, per the screens we rannon-permissible income 13.8%, above the 5% limit
Oncolys BioPharma, Inc stock (4588) is not compliant with AAOIFI Shari'ah Standard No. 21 per our screen dated 2026-10-29: non-permissible income (interest) is 13.8% of total revenue, above the 5% limit.
Purification shareNot yet computed
Follow it in your portfolioFollow this stock on Telegram for free
- Price
- 6,980 JPYLast close 2026-10-27
- Market cap
- 182.17 B JPYat the 2026-10-27 close
- Symbol
- TSE:4588
- Market
- Tokyo Stock Exchange
- Sector
- Health Technology
- Industry
- Biotechnology
Identity page only: this company is inside our coverage, but its fundamental figures are incomplete at the source, so it enters no scoring and no ranking.
Figures as of 2026-10-29 13:13
Sharia screening
Not compliant, per the screens we ran
We apply AAOIFI Shari'ah Standard No. 21, Financial Paper (Shares and Bonds), issued on 30 Rabi' I 1425 AH (20 May 2004), as published on AAOIFI's website. We last reviewed its limits on 2026-10-01. We read what the standard says; we do not issue fatwas.
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
Oncolys BioPharma, Inc in numbers
Oncolys BioPharma, Inc ranks 28 of 131 in the Health Technology sector on Tokyo Stock Exchange by market cap (182.17 B JPY). Its debt-to-equity ratio is 0.25.
Published figures with their date, not financial advice. Market cap and P/E use the 2026-10-27 close.
The five screens, one by one
Sharia safety margin: 0 / 100 · Not compliant: far from the limit, or an excluded activity · Not applied: receivables · as of 2026-10-29
Sharia safety margin: 0 / 100 · Not compliant: far from the limit, or an excluded activity · Not applied: receivables · as of 2026-10-29
We ran 4 of 5 screens; the Sharia safety margin is 0 / 100.
| Business activity (sector and industry) | No excluded activity in its sector or industry | Passed |
| Interest-bearing debt to market cap | under 1%, limit 30% | Passed |
| Cash and interest-bearing securities to market cap | 3%, limit 30% | Passed |
| Non-permissible income to revenue | 13.8%, limit 5% | Did not pass |
| Receivables to market cap | Not run: the standard sets no limit for it |
Purification share
We have not yet measured the share of this company's revenue that comes from non-permissible income, so we show no purification share and do not guess one. We do not publish a per-share amount.
Figures as of 2026-10-29 13:13
Company facts
- Debt-to-equity ratio 0.25
Figures computed from the company's published financial statements and read on 2026-10-29. They move with every new statement; this states a figure, it is an educational reading, not financial advice.
Fundamental filter
Below the stated threshold
- The company actually earned a profit over the last twelve months. Not met
- Its debt does not exceed twice its shareholders' equity. Met
- The rest of the fundamental filter: every check in full, with its state — met, not met, or not measured.
- And whatever the source does not publish is named as such — never counted as a met check.
These are this page's items only; each plan's full list is on the pricing page.
Figures as of 2026-10-29
An automated quality screen on published figures, not financial advice. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
Today's model reading
The same four tools that read the daily report's markets, applied to this stock's completed bars.
- Today's call on this stock — up, down, or no call — and how many model votes stand behind it.
- All four tools one by one: cycles, historical analogue, seasonal pattern and momentum — each with its lean and its figure, and any tool that gave no read is named as such.
- Last completed close, average daily range, twenty-day range and the month band — shown when this stock has enough bars to compute them.
These are this page's items only; each plan's full list is on the pricing page.
Completed bars through 2026-10-27 · 3145 bars
Automated educational reading, not a recommendation. The decision is yours.
Frequently asked about Oncolys BioPharma, Inc
What is the Sharia safety margin of Oncolys BioPharma, Inc?
For Oncolys BioPharma, Inc, Sharia safety margin: 0 / 100 · Not compliant: far from the limit, or an excluded activity · Not applied: receivables · as of 2026-10-29. The Sharia safety margin, out of 100, measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on the page.
Does Oncolys BioPharma, Inc stock need purification?
We have not yet measured the share of this company's revenue that comes from non-permissible income, so we show no purification share and do not guess one. We do not publish a per-share amount.
How do I work out zakat on Oncolys BioPharma, Inc shares?
The zakat calculator on this site gives an indicative amount from the value of the shares you hold; detailed rulings belong to scholars.
Which market lists Oncolys BioPharma, Inc?
Oncolys BioPharma, Inc is listed on Tokyo Stock Exchange under the symbol 4588.
What the subscription adds
This page is open to everyone. Inside the subscription this stock also carries its composite score and its parts, valuation ratios, its share of its sector, a read of its financial statements, and following it from your account. None of them is financial advice.